ADHD Trial, Recruiting NCT06456372 Sponsor: University of California, Riverside Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06456372
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have already been diagnosed with ADHD by a doctor or psychologist, based on DSM-5TR criteria, at the time they enter the program.
  • People who are able to complete questionnaires and use a smartphone app in English.
  • People with a reported IQ of at least 80, to help ensure the cognitive skills needed to use the app are in place.
  • People who have a parent or guardian available who can give consent and provide feedback in English.

Who may not be able to join:

  • People who do not meet all of the above requirements may not be eligible to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 951-827-0741

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Riverside
Registry
ClinicalTrials.gov
Start date
22 February 2025
Est. completion
29 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Child Self-Regulation - BASC-3 SRP, PRS, TRS; ADHD Symptoms - BASC-3 SRP, PRS, TRS; ADHD Symptoms - Brown EF/A; ADHD Symptoms - SWAN; Parent Self-Regulation - BASC-3 PRQ; Engagement in Care - PAM Child; Engagement in Care - PAM Parent; Perceptions of Shared-Decision Making and Treatment Collaborations - Child & Parent; Perceptions of Shared-Decision Making and Treatment Collaborations - Provider/Educator

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov